RLAY insider buying and SEC filings, explained
Relay Therapeutics, Inc. · CIK 1812364
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$117.8M
Planned sales (10b5-1)
$11.8M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 28, 2026 | Sale | Peter Rahmer (Chief Corporate Development Officer) sold 753 shares at $18.62 ($14K). Holdings down <1% to 222,904 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 30, 2026, 4:18 PM ET |
| Oct 28, 2026 | Sale | Donald A Bergstrom (President / COO) sold 2,252 shares at $18.62 ($42K). Holdings down 1% to 396,878 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 30, 2026, 4:15 PM ET |
| Oct 28, 2026 | Sale | Thomas Catinazzo (CFO) sold 1,469 shares at $18.62 ($27K). Holdings down 1% to 103,665 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 30, 2026, 4:14 PM ET |
| Oct 7, 2026 | Planned (10b5-1) | Sanjiv Patel (CEO and Director) sold 48,199 shares at about $18.10 ($872K), marked as a 10b5-1 plan trade. Holdings down 9% to 471,301 shares. | SEC filing Filed Oct 8, 2026, 5:29 PM ET |
| Oct 6, 2026 | Planned (10b5-1) | Thomas Catinazzo (CFO) sold 17,717 shares at about $18.59 ($329K), marked as a 10b5-1 plan trade. Holdings down 14% to 105,134 shares. | SEC filing Filed Oct 8, 2026, 5:29 PM ET |
| Sep 8, 2026 | Planned (10b5-1) | Donald A Bergstrom (President / COO) sold 8,530 shares at about $18.97 ($162K), marked as a 10b5-1 plan trade. Holdings down 2% to 399,130 shares. | SEC filing Filed Sep 9, 2026 |
| Sep 8, 2026 | Planned (10b5-1) | Thomas Catinazzo (CFO) sold 17,717 shares at about $18.94 ($336K), marked as a 10b5-1 plan trade. Holdings down 13% to 122,851 shares. | SEC filing Filed Sep 9, 2026 |
| Sep 8, 2026 | Planned (10b5-1) | Sanjiv Patel (CEO and Director) sold 48,199 shares at about $18.94 ($913K), marked as a 10b5-1 plan trade. Holdings down 8% to 519,500 shares. | SEC filing Filed Sep 9, 2026 |
| Aug 26, 2026 | Planned (10b5-1) | Peter Rahmer (Chief Corporate Development Officer) sold 4,508 shares at about $20.03 ($90K), marked as a 10b5-1 plan trade. Holdings down 2% to 223,657 shares. | SEC filing Filed Aug 28, 2026 |
| Aug 25, 2026 | Sale | SB INVESTMENT ADVISERS (UK) LTD (10% owner) sold 6,000,000 shares indirectly at $19.40 ($116.4M). Indirect holdings down 22% to 21,904,963 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners. | SEC filing Filed Aug 28, 2026 |
| Aug 17, 2026 | Planned (10b5-1) | Sanjiv Patel (CEO and Director) sold 48,199 shares at about $20.33 ($980K), marked as a 10b5-1 plan trade. Holdings down 8% to 567,699 shares. | SEC filing Filed Aug 18, 2026 |
| Aug 14, 2026 | Planned (10b5-1) | Thomas Catinazzo (CFO) sold 17,717 shares at about $19.74 ($350K), marked as a 10b5-1 plan trade. Holdings down 11% to 140,568 shares. | SEC filing Filed Aug 18, 2026 |
| Jul 28, 2026 | Sale | Thomas Catinazzo (CFO) sold 1,459 shares at $18.61 ($27K). Holdings down 1% to 158,285 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 30, 2026 |
| Jul 28, 2026 | Sale | Peter Rahmer (Officer) sold 748 shares at $18.61 ($14K). Holdings down <1% to 228,165 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 30, 2026 |
| Jul 28, 2026 | Sale | Donald A Bergstrom (President / COO) sold 2,237 shares at $18.61 ($42K). Holdings down 1% to 407,660 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 30, 2026 |
| Jul 6, 2026 | Planned (10b5-1) | Donald A Bergstrom (President / COO) sold 8,660 shares at about $18.71 ($162K), marked as a 10b5-1 plan trade. Holdings down 2% to 409,897 shares. | SEC filing Filed Jul 8, 2026 |
| Jul 6, 2026 | Planned (10b5-1) | Thomas Catinazzo (CFO) sold 17,717 shares at about $18.69 ($331K), marked as a 10b5-1 plan trade. Holdings down 10% to 159,744 shares. | SEC filing Filed Jul 8, 2026 |
| Jul 7, 2026 | Planned (10b5-1) | Sanjiv Patel (CEO and Director) sold 48,199 shares at about $19.58 ($944K), marked as a 10b5-1 plan trade. Holdings down 7% to 615,898 shares. | SEC filing Filed Jul 8, 2026 |
| Jun 30, 2026 | Planned (10b5-1) | Peter Rahmer (Chief Corporate Development Officer) sold 50,000 shares at about $19.09 ($955K), marked as a 10b5-1 plan trade. Holdings down 18% to 225,857 shares. | SEC filing Filed Jul 2, 2026 |
| Jun 22, 2026 | Planned (10b5-1) | Thomas Catinazzo (CFO) sold 187,163 shares at about $16.97 ($3.2M), marked as a 10b5-1 plan trade. Holdings down 51% to 177,461 shares. | SEC filing Filed Jun 24, 2026 |
| Jun 22, 2026 | Planned (10b5-1) | Donald A Bergstrom (President / COO) sold 93,456 shares at about $16.94 ($1.6M), marked as a 10b5-1 plan trade. Holdings down 18% to 418,557 shares. | SEC filing Filed Jun 24, 2026 |
| May 14, 2026 | Planned (10b5-1) | Thomas Catinazzo (CFO) sold 17,717 shares at about $12.86 ($228K), marked as a 10b5-1 plan trade. Holdings down 8% to 195,178 shares. | SEC filing Filed May 14, 2026 |
| Apr 28, 2026 | Sale | Thomas Catinazzo (CFO) sold 972 shares at $14.79 ($14K). Holdings down <1% to 212,895 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 30, 2026 |
| Apr 28, 2026 | Sale | Peter Rahmer (Chief Corporate Development Officer) sold 753 shares at $14.79 ($11K). Holdings down <1% to 275,857 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 30, 2026 |
| Apr 28, 2026 | Sale | Donald A Bergstrom (President / COO) sold 1,490 shares at $14.79 ($22K). Holdings down <1% to 418,557 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 30, 2026 |
| Apr 7–9, 2026 | Planned (10b5-1) | Thomas Catinazzo (CFO) sold 19,517 shares between Apr 7 and Apr 9 at about $13.19 ($257K), marked as a 10b5-1 plan trade. Holdings down 8% to 213,867 shares. | SEC filing Filed Apr 9, 2026 |
| Mar 9, 2026 | Planned (10b5-1) | Thomas Catinazzo (CFO) sold 17,717 shares at about $10.06 ($178K), marked as a 10b5-1 plan trade. Holdings down 7% to 231,584 shares. | SEC filing Filed Mar 11, 2026 |
| Jan 27–28, 2026 | Sale | Donald A Bergstrom (President / COO) sold 21,581 shares between Jan 27 and Jan 28 at about $7.72 ($167K). Holdings down 5% to 420,047 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 29, 2026 |
| Jan 27–28, 2026 | Sale | Thomas Catinazzo (CFO) sold 15,515 shares between Jan 27 and Jan 28 at about $7.71 ($120K). Holdings down 6% to 249,301 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 29, 2026 |
| Jan 27–28, 2026 | Sale | Peter Rahmer (Chief Corporate Development Officer) sold 13,038 shares between Jan 27 and Jan 28 at about $7.71 ($100K). Holdings down 5% to 276,610 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 29, 2026 |
| Jan 6, 2026 | Sale | Sanjiv Patel (CEO and Director) sold 43,168 shares at $7.82 ($338K). Holdings down 6% to 661,041 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 7, 2026 |
| Nov 3, 2025 | Sale | Sanjiv Patel (CEO and Director) sold 62,073 shares at $7.00 ($435K). Holdings down 8% to 703,215 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 4, 2025 |
20 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow RLAY in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.